SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001125282-06-003384
Filing Date
2006-06-12
Accepted
2006-06-12 13:26:12
Documents
1
Period of Report
2006-04-17

Document Format Files

Seq Description Document Type Size
1 form.html 4  
1 form.xml 4 3715
  Complete submission text file 0001125282-06-003384.txt   5520
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 33 HARBOUR SQUARE SUITE 202 TORONTO ONTARIO A6 M5J 2G2 4163642551
BERNSTEIN GERALD (Reporting) CIK: 0001205433 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 06899224